Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Retrospective analysis of Porphyromonas gingivalis in patients with nasopharyngeal carcinoma in central China

Retrospective analysis of Porphyromonas gingivalis in patients with nasopharyngeal carcinoma in... Little is known about the presence and possible role of Porphyromonas gingivalis (P. gingivalis) in nasopharyngeal carcinoma (NPC), its co‑infection with Epstein‑Barr virus (EBV), or their association with clinical characteristics of patients with NPC in Central China, where NPC is non‑endemic. A total of 45 NPC formalin‑fixed paraffin‑embedded (FFPE) tissues were retrospectively analyzed using immunohistochemistry (IHC) and a nested PCR combined with DNA sequencing to detect the presence of P. gingivalis, and using reverse transcription‑quantitative PCR to detect the presence of EBV. Clinical data including EBV and P. gingivalis status were associated with overall survival (OS). All tumors were undifferentiated, non‑keratinizing carcinomas, of which 40/45 (88.9%) were positive for EBV (EBV+), 26/45 (57.8%) were positive for P. gingivalis (by IHC), and 7/45 (15.6%) were positive for P. gingivalis DNA (P. gingivalis+). All seven P. gingivalis DNA‑positive NPCs were co‑infected with EBV. The 5‑year survival rates of the patients with EBV‑/P. gingivalis‑, EBV+/P. gingivalis‑, and EBV+/P. gingivalis+ tumors were 60.0% (3/5), 39.4% (13/33) and 42.9% (3/7), respectively. No significant difference was found between the OS of NPC patients among the different infection groups (P=0.793). In conclusion, to the best of our knowledge, this is the first study to describe and confirm the presence of P. gingivalis in FFPE tissues from patients with NPC. P. gingivalis was found to co‑exist with EBV in NPC tumor tissues, but is not etiologically relevant to NPC in non‑endemic areas, such as Central China. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular and Clinical Oncology Spandidos Publications

Retrospective analysis of Porphyromonas gingivalis in patients with nasopharyngeal carcinoma in central China

Download PDF
9 pages

Loading next page...
 
/lp/spandidos-publications/retrospective-analysis-of-porphyromonas-gingivalis-in-patients-with-hSinD2W7xu

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Spandidos Publications
Copyright
Copyright \xC2\xA9 2023 Spandidos Publications
ISSN
2049-9450

Abstract

Little is known about the presence and possible role of Porphyromonas gingivalis (P. gingivalis) in nasopharyngeal carcinoma (NPC), its co‑infection with Epstein‑Barr virus (EBV), or their association with clinical characteristics of patients with NPC in Central China, where NPC is non‑endemic. A total of 45 NPC formalin‑fixed paraffin‑embedded (FFPE) tissues were retrospectively analyzed using immunohistochemistry (IHC) and a nested PCR combined with DNA sequencing to detect the presence of P. gingivalis, and using reverse transcription‑quantitative PCR to detect the presence of EBV. Clinical data including EBV and P. gingivalis status were associated with overall survival (OS). All tumors were undifferentiated, non‑keratinizing carcinomas, of which 40/45 (88.9%) were positive for EBV (EBV+), 26/45 (57.8%) were positive for P. gingivalis (by IHC), and 7/45 (15.6%) were positive for P. gingivalis DNA (P. gingivalis+). All seven P. gingivalis DNA‑positive NPCs were co‑infected with EBV. The 5‑year survival rates of the patients with EBV‑/P. gingivalis‑, EBV+/P. gingivalis‑, and EBV+/P. gingivalis+ tumors were 60.0% (3/5), 39.4% (13/33) and 42.9% (3/7), respectively. No significant difference was found between the OS of NPC patients among the different infection groups (P=0.793). In conclusion, to the best of our knowledge, this is the first study to describe and confirm the presence of P. gingivalis in FFPE tissues from patients with NPC. P. gingivalis was found to co‑exist with EBV in NPC tumor tissues, but is not etiologically relevant to NPC in non‑endemic areas, such as Central China.

Journal

Molecular and Clinical Oncology – Spandidos Publications

Published: Apr 23, 2023

There are no references for this article.